|
|
||||||||
Concise Reviews |
a Division of Human Immunology, The Hanson Centre for Cancer Research, The Institute of Medical and Veterinary Science, Adelaide, SA, Australia;
b The Baker Research Institute, Melbourne, Victoria, Australia
Key Words. Colony-stimulating factor • Hematopoiesis • Receptor • Signal transduction
Dr. Angel F. Lopez, Division of Human Immunology, The Hanson Centre for Cancer Research, The Institute of Medical and Veterinary Science, Adelaide, 5000 SA, Australia.
The process of ligand binding leading to receptor activation is an ordered and sequential one. High-affinity binding of GM-CSF, interleukin 3 (IL-3), and IL-5 to their receptors induces a number of key events at the cell surface and within the cytoplasm that are necessary for receptor activation. These include receptor oligomerization, activation of tyrosine kinase activity, phosphorylation of the receptor, and the recruitment of SH2 (src-homology) and PTB (phosphotyrosine binding) domain proteins to the receptor. Such a sequence of events represents a recurrent theme among cytokine, growth factor, and hormone receptors; however, a number of very recent and interesting findings have identified unique features in this receptor system in terms of: A) how GM-CSF/IL-3/IL-5 bind, oligomerize, and activate their cognate receptors; B) how multiple biological responses such as proliferation, survival, and differentiation can be transduced from activated GM-CSF, IL-3, or IL-5 receptors, and C) how the presence of novel phosphotyrosine-independent signaling motifs within a specific cytoplasmic domain of ßC may be important for mediating survival and differentiation by these cytokines. This review does not attempt to be all-encompassing but rather to focus on the most recent and significant discoveries that distinguish the GM-CSF/IL-3/IL-5 receptor subfamily from other cytokine receptors.
This article has been cited by other articles:
![]() |
M. Espia, C. Sebastian, M. Mulero, M. Giralt, J. Mallol, A. Celada, and J. Lloberas Granulocyte Macrophage-Colony-Stimulating Factor-Dependent Proliferation Is Impaired in Macrophages From Senescence-Accelerated Mice J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2008; 63(11): 1161 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milanovic, G. Terszowski, D. Struck, O. Liesenfeld, and D. Carstanjen IFN Consensus Sequence Binding Protein (Icsbp) Is Critical for Eosinophil Development J. Immunol., October 1, 2008; 181(7): 5045 - 5053. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Ramshaw, M. A. Guthridge, F. C. Stomski, E. F. Barry, L. Ooms, C. A. Mitchell, C. G. Begley, and A. F. Lopez The Shc-binding site of the {beta}c subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis Blood, November 15, 2007; 110(10): 3582 - 3590. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Antignani and R. J. Youle The Cytokine, Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Can Deliver Bcl-XL as an Extracellular Fusion Protein to Protect Cells from Apoptosis and Retain Differentiation Induction J. Biol. Chem., April 13, 2007; 282(15): 11246 - 11254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martinez-Moczygemba, D. P. Huston, and J. T. Lei JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization J. Leukoc. Biol., April 1, 2007; 81(4): 1137 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Suh, M.-O. Kim, and S. C. Lee Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt J. Immunol., March 1, 2005; 174(5): 2712 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Groger, R. Loewe, W. Holnthoner, R. Embacher, M. Pillinger, G. S. Herron, K. Wolff, and P. Petzelbauer IL-3 Induces Expression of Lymphatic Markers Prox-1 and Podoplanin in Human Endothelial Cells J. Immunol., December 15, 2004; 173(12): 7161 - 7169. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Rao, I. Driver, D. A. Lauffenburger, and K. D. Wittrup Interleukin 2 (IL-2) Variants Engineered for Increased IL-2 Receptor {alpha}-Subunit Affinity Exhibit Increased Potency Arising from a Cell Surface Ligand Reservoir Effect Mol. Pharmacol., October 1, 2004; 66(4): 864 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Guthridge, E. F. Barry, F. A. Felquer, B. J. McClure, F. C. Stomski, H. Ramshaw, and A. F. Lopez The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-{kappa}B and induction of bcl-2 Blood, February 1, 2004; 103(3): 820 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Gaynor A role for extracellular matrix binding receptors in regulating hematopoietic growth factor signaling PNAS, November 25, 2003; 100(24): 13737 - 13738. [Full Text] [PDF] |
||||
![]() |
O. G. Ribeiro, D. A. Maria, S. Adriouch, S. Pechberty, W. H. K. Cabrera, J. Morisset, O. M. Ibanez, and M. Seman Convergent alteration of granulopoiesis, chemotactic activity, and neutrophil apoptosis during mouse selection for high acute inflammatory response J. Leukoc. Biol., October 1, 2003; 74(4): 497 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wong, J. McLaughlin, D. Cheng, K. Shannon, L. Robb, and O. N. Witte IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease PNAS, September 30, 2003; 100(20): 11630 - 11635. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. T. Phan, D. B. Shultz, B.-T. H. Truong, T. J. Blake, A. L. Brown, T. J. Gonda, M. M. Le Beau, and S. C. Kogan Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation Mol. Cell. Biol., July 1, 2003; 23(13): 4573 - 4585. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Wong, W. K. Ip, and C. W. K. Lam Interleukin-3, -5, and Granulocyte Macrophage Colony-Stimulating Factor-Induced Adhesion Molecule Expression on Eosinophils by p38 Mitogen-Activated Protein Kinase and Nuclear Factor-{kappa}B Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 133 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Carcamo, O. Borquez-Ojeda, and D. W. Golde Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways Blood, May 1, 2002; 99(9): 3205 - 3212. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Allakhverdi, M. Allam, and P. M. Renzi Inhibition of Antigen-induced Eosinophilia and Airway Hyperresponsiveness by Antisense Oligonucleotides Directed against the Common beta Chain of IL-3, IL-5, GM-CSF Receptors in a Rat Model of Allergic Asthma Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 1015 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Dijkers, K. U. Birkenkamp, E. W.-F. Lam, N. S. B. Thomas, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity J. Cell Biol., February 4, 2002; 156(3): 531 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Aldinucci, D. Poletto, A. Gloghini, P. Nanni, M. Degan, T. Perin, P. Ceolin, F. M. Rossi, V. Gattei, A. Carbone, et al. Expression of Functional Interleukin-3 Receptors on Hodgkin and Reed-Sternberg Cells Am. J. Pathol., February 1, 2002; 160(2): 585 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miura, S. S. Saini, G. Gauvreau, and D. W. MacGlashan Jr Differences in Functional Consequences and Signal Transduction Induced by IL-3, IL-5, and Nerve Growth Factor in Human Basophils J. Immunol., August 15, 2001; 167(4): 2282 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gauduchon, S. Werner, G. Prevost, H. Monteil, and D. A. Colin Flow Cytometric Determination of Panton-Valentine Leucocidin S Component Binding Infect. Immun., April 1, 2001; 69(4): 2390 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Lilly, M. Zemskova, A. E. Frankel, J. Salo, and A. S. Kraft Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor {alpha} subunit mediate activation of Jak/Stat signaling and differentiation Blood, March 15, 2001; 97(6): 1662 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Dijkers, R. H. Medema, C. Pals, L. Banerji, N. S. B. Thomas, E. W.-F. Lam, B. M. T. Burgering, J. A. M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, et al. Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27KIP1 Mol. Cell. Biol., December 15, 2000; 20(24): 9138 - 9148. [Abstract] [Full Text] |
||||
![]() |
C. W. M. Reuter, M. A. Morgan, and L. Bergmann Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood, September 1, 2000; 96(5): 1655 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Le, F. Stomski, J. M. Woodcock, A. F. Lopez, and T. J. Gonda The Role of Disulfide-linked Dimerization in Interleukin-3 Receptor Signaling and Biological Activity J. Biol. Chem., February 18, 2000; 275(7): 5124 - 5130. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.C. Stomski, M. Dottore, W. Winnall, M.A. Guthridge, J. Woodcock, C.J. Bagley, D.T. Thomas, R.K. Andrews, M.C. Berndt, and A.F. Lopez Identification of a 14-3-3 Binding Sequence in the Common beta Chain of the Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-3 (IL-3), and IL-5 Receptors That Is Serine-Phosphorylated by GM-CSF Blood, September 15, 1999; 94(6): 1933 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Dijkers, K. U. Birkenkamp, E. W.-F. Lam, N. S. B. Thomas, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity J. Cell Biol., February 4, 2002; 156(3): 531 - 542. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
